A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus ...
In a recent study published in JAMA, researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate coronavirus disease 2019 ...
A Houston doctor says he is using the anti-parasite medication ivermectin with a combination of drugs to treat COVID-19 patients, despite warnings from federal health officials that it could cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback